IP Library › Assignment 016309/0812
Patent Assignment
Reel/Frame 016309/0812

Change of Name

Recorded: 2005-06-07 Pages: 12
Assignor
ARROW ACQUISITION, LLC
Executed: 2004-08-13
Assignee
AMGEN SF, LLC
1120 VETERANS BOULEVARD, SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties (347)
Host Cell Factor, Nucleic Acids Encoding Hcf, and Methods of Use
Application: 07/989,842 →
Novel Eukaryotic Transcription Protein: Host Cell Factor
Patent: 5,453,362 →
Application: 08/046,585 →
Transcription Factor-Dna Binding Assay
Patent: 5,563,036 →
Application: 08/235,503 →
Epstein-Barr Virus Transcription Factor Binding Assay
Application: 08/246,977 →
Interleukin 4 Signal Transducers and Binding Assays
Application: 08/269,604 →
Nuclear Factors and Binding Assay
Application: 08/270,653 →
Interleukin 4 Signal Transducers
Patent: 5,591,825 →
Application: 08/276,099 →
High-Throughput Screening Assay for Inhibitors of Nucleic Acid Polymerases
Patent: 5,635,349 →
Application: 08/348,797 →
Interleukin-2 Signal Transducers and Binding Assays
Patent: 5,618,693 →
Application: 08/393,333 →
Herpes Simplex Virus Drug Screen
Patent: 5,585,239 →
Application: 08/393,703 →
Nuclear Factors and Binding Assay
Patent: 5,612,455 →
Application: 08/396,479 →
Human Signal Transducer and Binding Assays
Patent: 5,639,858 →
Application: 08/408,318 →
Tnf Receptor-Associated Intracellular Signaling Proteins and Methods of Use
Patent: 5,563,039 →
Application: 08/414,625 →
Interleukin-1 Receptor-Associated Protein Kinase and Assays
Application: 08/494,006 →
Inhibitors of Apoptosis
Application: 08/512,946 →
Rip: Novel Human Protein Involved in Tumor Necrosis Factor Signal Transduction, and Screening Assays
Application: 08/553,727 →
Transcriptional Promoter of the Murine Obesity Gene
Patent: 5,698,389 →
Application: 08/558,545 →
C-Iap 1 and C-Iap 2: Inhibitors of Apoptosis
Patent: 6,187,557 →
Application: 08/569,749 →
Interleukin-1 Receptor-Associated Protein Kinase and Assays
Patent: 5,654,397 →
Application: 08/587,889 →
Pentafluorobenzenesulfonamides and Analogs
Application: 08/605,431 →
High-Throughput Screening Assay for Inhibitors of Nucleic Acid Helicases
Patent: 5,705,344 →
Application: 08/616,046 →
Tumor Necrosis Factor Receptor Associated Factor 6 (TRAF6)
Patent: 5,710,013 →
Application: 08/639,237 →
Human Telomerase Rna Interacting Protein Gene
Patent: 5,747,317 →
Application: 08/676,967 →
Assays Using TRAF2-Associated Protein Kinase Polypeptides
Patent: 5,874,230 →
Application: 08/677,862 →
Kinase Assay
Patent: 5,759,787 →
Application: 08/702,970 →
Epstein-Barr Virus Transcription Factor Binding Assay
Patent: 5,679,525 →
Application: 08/704,398 →
Drug Screens for Regulators of the Expression of the Obese Gene
Patent: 5,780,258 →
Application: 08/707,408 →
Nucleic Acid Encoding an Interleukin 4 Signal Transducer
Patent: 5,710,266 →
Application: 08/781,890 →
Regulators of Apoptosis
Patent: 6,242,569 →
Application: 08/795,088 →
Ikb Kinases
Patent: 5,837,514 →
Application: 08/812,533 →
Nuclear Factors and Binding Assays
Patent: 5,708,158 →
Application: 08/818,823 →
STAT6 Deficient Transgenic Mice
Patent: 5,866,760 →
Application: 08/823,051 →
Nucleic Acid Encoding Human Signal Transducer and Activator of Transcription 4
Patent: 5,756,700 →
Application: 08/839,164 →
Regulators of UCP2 Gene Expression
Patent: 5,807,740 →
Application: 08/846,012 →
Cell-Based Drug Screens for Regulators of Gene Expression
Patent: 6,566,089 →
Application: 08/866,942 →
High Throughout Nucleic Acid Primase Assay
Application: 08/882,606 →
Ikk-Beta Proteins, Nucleic Acids and Methods
Application: 08/887,114 →
Ikk -a Proteins, Nucleic Acids and Methods
Application: 08/887,115 →
Nucleic Acids Encoding Human Nik Protein
Patent: 5,843,721 →
Application: 08/887,518 →
Ikk-B Proteins, Nucleic Acids and Methods
Patent: 5,851,812 →
Application: 08/890,853 →
Ikk-Alpha Proteins, Nucleic Acids and Methods
Patent: 6,235,512 →
Application: 08/890,854 →
Pentafluorobenzenesulfonamides and Analogs
Patent: 6,482,860 →
Application: 08/896,280 →
Pentafluorobenzenesulfonamides and Analogs
Patent: 5,880,151 →
Application: 08/896,827 →
Substituted Benzene Compounds as Antiproliferative and Cholesterol Lowering Agents
Patent: 6,284,923 →
Application: 08/917,025 →
Nucleic Acids Encoding Murine UCP3 Genes
Patent: 5,846,779 →
Application: 08/937,466 →
Regulators of UCP3 Gene Expression
Patent: 5,849,581 →
Application: 08/948,277 →
Ikap Nucleic Acids
Patent: 5,891,719 →
Application: 08/971,244 →
Ikb Kinases
Patent: 5,776,717 →
Application: 08/971,937 →
Novel Protein-TRAF6
Patent: 5,767,244 →
Application: 08/975,405 →
Nuclear Hormone Receptor Drug Screens
Patent: 6,555,326 →
Application: 08/975,614 →
Interleukin-1 Receptor Accessory Proteins, Nucleic Acids and Methods
Patent: 6,280,955 →
Application: 08/991,944 →
Human Nik Protein
Patent: 5,844,073 →
Application: 09/023,321 →
Ikk-Alpha Proteins, Nucleic Acids and Methods
Patent: 6,235,513 →
Application: 09/023,324 →
High Throughput Screening Assays for Nucleic Acid Ligase Modulators
Patent: 6,153,384 →
Application: 09/025,979 →
Screening Method for Agents That Modulate Human Nik Activity
Patent: 5,854,003 →
Application: 09/032,475 →
Ikk-A Proteins, Nucleic Acids and Methods
Patent: 6,235,492 →
Application: 09/032,476 →
Suppressors of Death Domains
Patent: 6,437,113 →
Application: 09/035,676 →
High-Throughput Screening Assays for Modulators of Nucleic Acid Topoisomerases
Patent: 5,998,152 →
Application: 09/037,154 →
High Throughput Assay for Detection of Mrna in Cells
Application: 09/052,841 →
High-Throughput Screening Assays for Modulators of Primase Activity
Patent: 6,043,038 →
Application: 09/052,924 →
High Throughput in Vitro Screening Assays for Transcription Modulators
Patent: 6,183,956 →
Application: 09/052,995 →
High-Throughput Screening Assays for Modulators of STAT4 and STAT6 Activity
Patent: 6,207,391 →
Application: 09/053,003 →
Human Telomerase Gene Rna Interacting Protein Gene
Patent: 5,888,747 →
Application: 09/072,270 →
High-Throughput in Vitro Assays for Modulators of Peptidyl Transferase
Patent: 5,962,244 →
Application: 09/074,580 →
Ikk-Beta Proteins, Nucleic Acids and Methods
Patent: 5,939,302 →
Application: 09/099,124 →
Ikk-Bproteins Nucleic Acids and Methods
Patent: 5,916,760 →
Application: 09/099,125 →
Method of Identifying Agents That Modulate UCP2 Promoter Activity
Patent: 5,849,514 →
Application: 09/100,297 →
Ikk-Alpha Proteins Nucleic Acids and Methods
Patent: 6,479,266 →
Application: 09/109,986 →
Drug Screens for Regulators of the Expression of the Obese Gene
Patent: 6,432,654 →
Application: 09/114,552 →
Human Uncoupling Protein 2 (HUCP2): Compositions and Methods of Use
Application: 09/124,293 →
High-Throughput in Vitro Screening Assays for Modulators of Nucleic Acid Helicases
Patent: 6,569,619 →
Application: 09/124,312 →
Novel Retinal Nuclear Hormore Receptor
Application: 09/130,858 →
Rip: Novel Human Protein Involved in Tumor Necrosis Factor Signal Transduction
Patent: 6,211,337 →
Application: 09/132,118 →
Isolated Nucleic Acids Encoding CYP7 Promoter-Binding Factors
Patent: 5,958,697 →
Application: 09/132,619 →
IRAK3 Polypeptides and Methods
Patent: 6,262,228 →
Application: 09/135,232 →
Nuclear Hormone Receptor Drug Screens
Patent: 7,101,681 →
Application: 09/163,713 →
Assays for Identifying Agents Which Affect Regulators of UCP3 Gene Expression
Patent: 5,976,808 →
Application: 09/169,203 →
Murine UCP3 Polypeptides
Patent: 5,952,469 →
Application: 09/172,528 →
Human Retinoid-Like Orphan Receptor Gamma
Application: 09/178,358 →
CANDIDA ALBICANS mRNA 5'-TRIPHOSPHATASE (CET-1) POLYNUCLEOTIDES
Application: 09/213,678 →
Publication: US 2002/0018774
Benzenesulfonamides and Benzamides as Therapeutic Agents
Patent: 6,191,170 →
Application: 09/226,703 →
Pentafluorobenzenesulfonamides and Analogs
Patent: 6,121,304 →
Application: 09/227,216 →
Ppar-Gamma Modulators
Patent: 6,200,995 →
Application: 09/234,327 →
Pyrimidine Derivatives
Patent: 6,200,977 →
Application: 09/249,641 →
TRAF2-Associated Protein Kinase and Assays
Patent: 5,981,250 →
Application: 09/252,571 →
CYP7 Promoter-Binding Factors
Patent: 6,027,901 →
Application: 09/282,803 →
Ikap Proteins and Methods
Patent: 6,172,195 →
Application: 09/286,891 →
Murine UCP3 Polypeptides
Patent: 6,025,469 →
Application: 09/318,199 →
Arylsulfonanilide Phosphates
Application: 09/336,062 →
Inhibitors of Stat Function
Patent: 6,426,331 →
Application: 09/349,208 →
High-Throughput Screening Assays for Modulators of Nucleic Acid Topoisomerases
Patent: 6,197,527 →
Application: 09/351,662 →
Arylsulfonanilide Derivatives
Patent: 6,153,585 →
Application: 09/353,976 →
Detection Method for Monitoring Beta Tubulin Isotype Specific Modification
Patent: 6,306,615 →
Application: 09/377,554 →
Ldl Receptor Gene Expression Promoters
Patent: 6,159,974 →
Application: 09/381,829 →
Arylsulfonanilide Ureas
Patent: 6,214,880 →
Application: 09/399,907 →
Sodd-Specific Antibodies and Methods
Patent: 6,110,690 →
Application: 09/416,213 →
Methods for Detecting Sodd Genes and Proteins
Patent: 6,413,728 →
Application: 09/416,214 →
Sodd Gene Expression in Cancer
Patent: 6,372,444 →
Application: 09/417,559 →
TRAF2-Associated Protein Kinase and Assays
Patent: 6,107,074 →
Application: 09/434,065 →
Methods of Assaying for Compounds That Inhibit Premature Translation Termination and Nonsense-Mediated Rna Decay
Patent: 6,458,538 →
Application: 09/461,508 →
Certain Polycyclic Compounds Useful as Tubulin-Binding Agents
Patent: 6,433,187 →
Application: 09/464,217 →
Fxr Receptor-Mediated Modulation of Cholesterol Metabolism
Patent: 6,465,258 →
Application: 09/478,948 →
Lxr Modulators
Patent: 6,906,069 →
Application: 09/479,315 →
UCP3 genes
Patent: 6,248,561 →
Application: 09/503,579 →
Recombinant Polynucleotides Encoding CYP7 Promoter-Binding Factors
Patent: 6,297,019 →
Application: 09/510,654 →
T2K Kinase Assays
Patent: 6,365,366 →
Application: 09/524,435 →
G-Protein Coupled Receptors Amlified in Breast Cancer
Patent: 6,638,733 →
Application: 09/524,730 →
LXR modulators
Patent: 6,316,503 →
Application: 09/525,861 →
G-Protein Coupled Receptor Bca-Gpcr-3
Patent: 6,635,741 →
Application: 09/546,986 →
High-throughput screening assays for modulators of mitochondrial membrane potential
Application: 09/567,856 →
Publication: US 2003/0170606
Arylsulfonanilide phosphates
Patent: 6,211,167 →
Application: 09/595,398 →
Compounds for the Modulation of Ppary Activity
Patent: 7,041,691 →
Application: 09/606,433 →
Combination therapy using pentafluorobenzenesulfonamides
Patent: 6,355,628 →
Application: 09/627,041 →
Pentafluorobenzenesulfonamides and analogs
Patent: 6,316,484 →
Application: 09/633,740 →
Arylsulfonanilide Derivates
Patent: 6,630,513 →
Application: 09/671,937 →
Modulators of Srebp Processing
Patent: 6,649,593 →
Application: 09/680,571 →
Inhibitors of Apoptosis
Patent: 6,821,736 →
Application: 09/689,366 →
Chandra: a Novel TH1-Specific Gene
Patent: 6,489,453 →
Application: 09/694,094 →
Nik-Knockout Mice
Patent: 6,822,138 →
Application: 09/706,236 →
Benzenesulfonamides and Benzamides as Therapeutic Agents
Patent: 6,583,161 →
Application: 09/736,040 →
Pyrimidine Derivatives
Patent: 6,528,513 →
Application: 09/737,983 →
Publication: US 2001/0018436
Ppargamma Modulators
Patent: 6,620,827 →
Application: 09/741,415 →
Publication: US 2001/0027200
Arylsulfonic Acid Salts of Pyrimidine-Based Antiviral
Patent: 6,410,726 →
Application: 09/757,291 →
Publication: US 2002/0065279
Rip: Novel Human Protein Involved in Tumor Necrosis Factor Signal Transduction
Patent: 7,029,871 →
Application: 09/758,003 →
Publication: US 2002/0098522
Irak-4: Compositions and Methods of Use
Patent: 6,818,419 →
Application: 09/759,595 →
Publication: US 2003/0059916
Antibacterial Agents
Patent: 6,780,858 →
Application: 09/759,633 →
Publication: US 2002/0045749
Car modulators: screening and treatment of hypercholesterolemia
Application: 09/760,364 →
Publication: US 2002/0152479
Arylsulfonanilide Phosphates
Patent: 6,417,176 →
Application: 09/779,419 →
Publication: US 2001/0018430
Therapeutic agent for hyperlipidemia
Application: 09/782,535 →
Publication: US 2002/0119958
Arylsulfonanilide Ureas
Patent: 6,583,165 →
Application: 09/792,669 →
Publication: US 2001/0027211
Hydrazones and Analogs as Cholesterol Lowering Agents
Patent: 6,605,615 →
Application: 09/798,247 →
Publication: US 2001/0056096
Nucleic Acid Encoding Kcnb Potassium Channel
Patent: 7,462,465 →
Application: 09/798,584 →
Publication: US 2002/0102676
High-Throughput Screening Assays for Modulators of STAT4 and STAT6 Activity
Patent: 6,682,898 →
Application: 09/818,094 →
Publication: US 2002/0039749
Solid Phase Synthesis of Lxr Ligands
Patent: 6,673,543 →
Application: 09/827,837 →
Publication: US 2002/0072073
NS5B Hcv Polymerase Inhibitors
Patent: 6,727,267 →
Application: 09/828,270 →
Publication: US 2002/0142290
Sitosterolemia Susceptibility Gene (Ssg): Compositions and Methods of Use
Patent: 7,033,810 →
Application: 09/837,992 →
Publication: US 2002/0081687
Combination Therapeutic Compositions and Method of Use
Patent: 6,653,332 →
Application: 09/847,887 →
Publication: US 2002/0037928
Pyrazole Antimicrobial Agents
Patent: 6,673,923 →
Application: 09/847,962 →
Publication: US 2002/0049205
Treatment of hypertriglyceridemia and other conditions using LXR modulators
Application: 09/848,990 →
Publication: US 2002/0048572
Polypeptides and Nucleic Acids Associated with Cancer
Patent: 6,919,176 →
Application: 09/850,948 →
Publication: US 2003/0059770
Regulators of Apoptosis
Patent: 7,528,244 →
Application: 09/861,270 →
Publication: US 2002/0052474
IRAK3 Polynucleotides
Patent: 6,576,444 →
Application: 09/863,549 →
Publication: US 2002/0049300
Substituted Benzene Compounds as Antiproliferative and Cholesterol Lowering Agents
Patent: 6,388,131 →
Application: 09/872,463 →
Publication: US 2002/0013496
Human uncoupling protein-2 (hCP2): compositions and methods of use
Application: 09/884,814 →
Publication: US 2002/0127600
Novel receptors
Application: 09/891,138 →
Publication: US 2003/0083245
Quinolinyl and Benzothiazolyl Modulators
Patent: 6,583,157 →
Application: 09/894,980 →
Publication: US 2002/0169185
Fxr Modulators
Patent: 6,777,446 →
Application: 09/945,293 →
Publication: US 2002/0120137
Pentafluorobenzenesulfonamides and Analogs
Patent: 7,138,418 →
Application: 09/972,743 →
Publication: US 2002/0143036
Modulation of CCR4 function
Application: 09/975,566 →
Publication: US 2002/0173524
ABCG8 Vectors, Host Cells, and Method of Making
Patent: 6,821,750 →
Application: 09/989,981 →
Publication: US 2003/0049730
Novel receptors
Application: 09/990,940 →
Publication: US 2003/0027252
Antiinflammation Agents
Patent: 6,846,834 →
Application: 10/004,287 →
Publication: US 2002/0161004
Stat Modulators
Patent: 6,884,782 →
Application: 10/008,244 →
Publication: US 2002/0151504
Lometrexol combination therapy
Application: 10/010,740 →
Publication: US 2002/0156023
Substituted Pyrido[2,3-D]Pyrimidines and Methods for Their Use
Patent: 6,964,967 →
Application: 10/015,532 →
Publication: US 2002/0169159
Novel G-protein coupled receptors
Application: 10/028,521 →
Publication: US 2006/0166309
Diagnosis and Treatment of Cancer Using Mammalian Pellino Polypeptides and Polynucleotides
Patent: 7,115,368 →
Application: 10/041,030 →
Publication: US 2002/0150934
Combination Therapy Using Pentafluorobenzenesulfonamides and Antineoplastic Agents
Patent: 6,822,001 →
Application: 10/052,905 →
Publication: US 2002/0177548
PRC17: an Amplified Cancer Gene
Application: 10/071,838 →
Publication: US 2003/0044814
Amplified cancer gene hepsin
Application: 10/073,060 →
Publication: US 2003/0049645
Amplified cancer gene WIP1
Application: 10/073,123 →
Publication: US 2003/0032027
Methods of using pyrimidine-based antiviral agents
Application: 10/078,246 →
Publication: US 2003/0130264
Novel receptors
Application: 10/094,417 →
Publication: US 2003/0045685
Ppargamma Modulators
Patent: 7,439,242 →
Application: 10/123,298 →
Publication: US 2003/0088103
Fused Heterocyclic Compounds
Patent: 6,858,619 →
Application: 10/138,279 →
Publication: US 2003/0023085
CCR4 Antagonists
Patent: 7,144,903 →
Application: 10/155,605 →
Publication: US 2003/0018022
Suppressors of Death Domains
Patent: 6,838,550 →
Application: 10/161,346 →
Publication: US 2003/0166193
CXCR3 Antagonists
Patent: 6,794,379 →
Application: 10/164,690 →
Publication: US 2003/0069234
Arylsulfonic Acid Salts of Pyrimidine-Based Antiviral Agents
Patent: 6,599,911 →
Application: 10/165,773 →
Publication: US 2003/0045715
Novel receptors
Application: 10/188,405 →
Publication: US 2003/0082585
Compounds for the Modulation of Ppargamma Activity
Patent: 6,770,648 →
Application: 10/209,205 →
Publication: US 2003/0139390
FXR receptor-mediated modulation of cholesterol metabolism
Application: 10/217,293 →
Publication: US 2003/0003520
Methods of Assaying for Compounds That Inhibit Premature Translation Termination and Nonsense-Mediated Rna Decay
Patent: 7,026,122 →
Application: 10/226,803 →
Publication: US 2003/0008317
Amplified gene involved in cancer
Application: 10/228,263 →
Publication: US 2003/0099985
Amplified oncogenes and their involvement in cancer
Application: 10/228,264 →
Publication: US 2003/0092042
Substituted Quinazolin-4(3H)-One Compounds, Compositions, and Methods for Their Use
Patent: 7,053,215 →
Application: 10/231,895 →
Publication: US 2003/0055054
Inhibitors of Apoptosis
Patent: 6,855,815 →
Application: 10/232,286 →
Publication: US 2003/0143579
Ikk-Alpha Proteins, Nucleic Acids and Methods
Patent: 7,045,613 →
Application: 10/243,408 →
Publication: US 2003/0077683
Linked Biaryl Compounds
Patent: 6,869,975 →
Application: 10/244,063 →
Publication: US 2003/0149108
Benzimidazole Derivatives
Patent: 7,132,438 →
Application: 10/268,412 →
Publication: US 2003/0144286
Pentafluorobenzenesulfonamides and Analogs
Patent: 6,962,929 →
Application: 10/270,259 →
Publication: US 2003/0162817
Polypeptides and nucleic acids associated with cancer
Application: 10/273,575 →
Publication: US 2003/0108931
Quinolinyl and Benzothiazolyl Modulators
Application: 10/278,851 →
Publication: US 2003/0171399
Gene amplification and overexpression in cancer
Application: 10/287,806 →
Publication: US 2003/0148341
Fused Heterocyclic Compounds
Patent: 6,809,104 →
Application: 10/289,933 →
Publication: US 2003/0176694
Chandra: a TH1-Specific Protein
Patent: 6,956,105 →
Application: 10/308,373 →
Publication: US 2003/0175265
Inflammation Modulators
Patent: 7,176,314 →
Application: 10/314,428 →
Publication: US 2003/0181472
Identification of an amplified gene and target for drug intervention
Application: 10/318,410 →
Publication: US 2003/0175763
Pyrimidine Derivatives
Patent: 6,835,726 →
Application: 10/350,801 →
Publication: US 2004/0006068
Arylsulfonamidobenzylic Compounds
Patent: 7,071,358 →
Application: 10/354,922 →
Publication: US 2003/0229093
Heterocyclic Arylsulfonamidobenzylic Compounds
Patent: 7,112,606 →
Application: 10/354,923 →
Publication: US 2003/0220339
Cell-Based Drug Screens for Regulators of Gene Expression
Patent: 7,105,313 →
Application: 10/365,958 →
Publication: US 2003/0153025
Arylsulfonanilide Ureas
Patent: 7,060,718 →
Application: 10/387,217 →
Publication: US 2003/0207864
Gene Amplification in Cancer
Patent: 6,974,672 →
Application: 10/390,191 →
Publication: US 2004/0005596
Amplification and overexpression of oncogenes
Application: 10/443,108 →
Publication: US 2004/0005615
Combination therapeutic compositions and method of use
Application: 10/456,932 →
Publication: US 2004/0259918
Bis-Aryl Thiazole Derivatives
Patent: 7,358,267 →
Application: 10/481,218 →
Publication: US 2005/0215608
Amplification and overexpression of oncogenes
Application: 10/623,810 →
Publication: US 2005/0059011
Novel G-Protein Coupled Receptors
Patent: 7,084,259 →
Application: 10/633,894 →
Publication: US 2004/0029232
Modulation of CCR4 Function
Patent: 7,262,204 →
Application: 10/654,112 →
Publication: US 2004/0039035
Antiinflammation Agents
Patent: 7,199,119 →
Application: 10/666,857 →
Publication: US 2004/0097485
Piperidine Derivatives
Patent: 7,045,527 →
Application: 10/669,606 →
Publication: US 2004/0142956
Receptor Ligands and Methods of Modulating Receptors
Patent: 7,056,685 →
Application: 10/703,145 →
Fused Heterocyclic Compounds
Patent: 7,253,179 →
Application: 10/705,173 →
Publication: US 2004/0147538
Amplified genes involved in cancer
Application: 10/715,117 →
Publication: US 2004/0171037
Receptor Ligands and Methods of Modulating Receptors
Patent: 7,189,524 →
Application: 10/719,692 →
Quinolinyl and Benzothiazolyl Modulators
Patent: 7,601,841 →
Application: 10/719,997 →
Publication: US 2004/0176409
Fused Bicyclic Nitrogen-Containing Heterocycles
Patent: 7,244,727 →
Application: 10/720,844 →
Publication: US 2004/0209871
Asthma and Allergic Inflammation Modulators
Patent: 7,321,001 →
Application: 10/742,281 →
Publication: US 2004/0220237
Solid phase synthesis of LXR ligands
Application: 10/749,530 →
Publication: US 2004/0152132
CXCR3 antagonists
Application: 10/789,165 →
Publication: US 2004/0242498
Fxr Modulators
Patent: 7,511,043 →
Application: 10/794,228 →
Publication: US 2004/0176426
Compounds for the Modulation of Ppary Activity
Patent: 7,626,033 →
Application: 10/810,325 →
Publication: US 2004/0248882
Gene amplification and overexpression in cancer
Application: 10/817,418 →
Publication: US 2005/0004059
Gene amplification and overexpression in cancer
Application: 10/867,183 →
Publication: US 2005/0026194
Antibacterial Agents
Patent: 7,053,234 →
Application: 10/877,408 →
Publication: US 2004/0235911
Asthma and allergic inflammation modulators
Application: 10/887,341 →
Publication: US 2005/0038070
Pyrrolo[1,2-B]Pyridazine Derivatives
Patent: 7,300,932 →
Application: 10/913,307 →
Publication: US 2005/0070545
Arylsulfonamidobenzylic compounds
Application: 10/916,868 →
Publication: US 2006/0264424
Fused Heterocyclic Compounds
Patent: 7,125,885 →
Application: 10/928,029 →
Publication: US 2005/0148617
Antiinflammation Agents
Patent: 7,186,841 →
Application: 10/928,784 →
Publication: US 2005/0043330
Inhibitors of Apoptosis
Patent: 6,964,765 →
Application: 10/934,717 →
Publication: US 2005/0037416
Linked Biaryl Compounds
Patent: 7,645,779 →
Application: 10/939,918 →
Publication: US 2008/0161351
CXCR3 Antagonists
Patent: 7,067,662 →
Application: 10/946,935 →
Publication: US 2005/0075333
Salts and Polymorphs of a Potent Antidiabetic Compound
Patent: 7,223,761 →
Application: 10/956,251 →
Publication: US 2005/0143416
Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
Application: 10/977,364 →
Irak-4: Compositions and Methods of Use
Patent: 7,235,635 →
Application: 10/990,276 →
Publication: US 2005/0255549
Combination therapy using pentafluorobenzenesulfonamides and antineoplastic agents
Application: 10/997,784 →
Publication: US 2005/0250854
STAT modulators
Application: 11/014,344 →
Publication: US 2005/0101540
Novel receptors
Application: 11/038,360 →
Publication: US 2005/0170397
STAT6 Deficient Transgenic Animals
Application: 60/013,981 →
Pentafluorobenzenesulfonamides and Analogs
Application: 60/022,198 →
CYP7 Promoter-Binding Factors
Application: 60/067,708 →
Benzenesulfonamides and Benzamides as Therapeutic Agents
Application: 60/071,137 →
Ppargamma Modulators
Application: 60/073,042 →
Pyrimidine Derivatives
Application: 60/075,005 →
Antiviral Agents
Application: 60/075,224 →
Arylsulfonanilide Phosphates
Application: 60/090,681 →
Stat Binding Agents
Application: 60/092,098 →
Arylsulfonanilide Derivatives
Application: 60/093,570 →
Arylsulfonanilide Ureas
Application: 60/100,888 →
Tubulin-Binding Agents
Application: 60/112,613 →
Fxr Receptor-Mediated Modulation of Cholesterol Metabolism
Application: 60/115,249 →
Lxr Modulators
Application: 60/115,292 →
Methods of Modulating Uric Acid Levels
Application: 60/116,392 →
Lxr Modulators
Application: 60/124,525 →
Mitochondrial Membrane Potential Assays
Application: 60/133,268 →
Compounds for the Modulation of Ppar-Gamma Activity
Application: 60/141,672 →
Combination Therapy Using Pentafluorobenzenesulfonamides
Application: 60/146,436 →
Modulators of Srebp Processing
Application: 60/159,236 →
Chandra: a Novel TH1-Specific Gene
Application: 60/161,201 →
Antibacterial Agents
Application: 60/175,892 →
Arylsulfonic Acid Salts of Pyrimidine-Based Antiviral Agents
Application: 60/176,000 →
Irak-4 : Compositions and Methods of Use
Application: 60/176,395 →
Car Modulators: Screening and Treatment of Hypercholesterolemia
Application: 60/176,398 →
Hydrazones as cholesterol lowering agents
Application: 60/186,047 →
Hydrazone analogs as cholesterol lowering agents
Application: 60/186,249 →
KCNB: a novel potassium channel protein
Application: 60/186,915 →
Solid phase synthesis of LXR ligands
Application: 60/194,911 →
NS5B HCV polymerase inhibitors
Application: 60/194,912 →
Sitosterolemia susceptibility gene (SSG): compositions and methods of use
Application: 60/198,465 →
Treatment of hypertriglyceridemia and other conditions using LXR modulators
Application: 60/201,601 →
Combination therapeutic compositions and methods of use
Application: 60/201,613 →
Pyrazole antibacterial agents
Application: 60/201,988 →
Sitosterolemia susceptibility gene (ssg):compositions and methods of use
Application: 60/204,234 →
Novel G-protein coupled receptors
Application: 60/213,461 →
Quinolinyl and benzothiazolyl modulators of PPARgamma activity
Application: 60/214,810 →
FXR modulators
Application: 60/230,585 →
Antiinflammation agents
Application: 60/243,581 →
Combination therapy using pentafluorobenzenesulfonamides and antineoplastics agents
Application: 60/245,878 →
Stat modulators
Application: 60/246,876 →
ABCG5 and ABCG8: compositions and methods of use
Application: 60/252,235 →
Novel g-protein coupled receptors
Application: 60/252,841 →
ABCG5 and ABCG8: compositions and methods of use
Application: 60/253,645 →
Lometrexol combination therapy
Application: 60/254,030 →
CXCR3 antagonists
Application: 60/255,241 →
TGR60: a novel oxytocin/vasopressin-related orphan GPCR
Application: 60/257,636 →
FXR modulators
Application: 60/258,092 →
Diagnosis and treatment of cancer using mammalian pellino polypeptides and polynucleotides
Application: 60/259,502 →
Lometrexol combination therapy
Application: 60/261,134 →
Novel receptor
Application: 60/261,377 →
PRC17: Amplified cancer gene
Application: 60/267,615 →
Amplified ovarian cancer gene hepsin
Application: 60/268,361 →
Amplified breast cancer gene WIP1
Application: 60/268,362 →
Methods of using pyrimidine-based antiviral agents
Application: 60/269,778 →
Novel receptors
Application: 60/276,649 →
TGR60: a novel oxytocin/vasopressin-related orphan GPCR
Application: 60/279,554 →
Novel receptor
Application: 60/280,696 →
Fused heterocyclic compounds
Application: 60/288,665 →
CCR4 antagonists
Application: 60/293,781 →
CXCR3 antagonists
Application: 60/296,499 →
Bis-aryl thiazole derivatives
Application: 60/302,193 →
Novel receptors
Application: 60/302,800 →
Amplified genes involved in cancer
Application: 60/314,655 →
Linked biaryl compounds
Application: 60/322,556 →
Benzimidazole derivatives
Application: 60/327,818 →
Amplified genes involved in cancer
Application: 60/330,797 →
Human MKPX gene: amplification and overexpression in cancer
Application: 60/331,394 →
Linked biaryl compounds
Application: 60/335,434 →
Inflammation modulators
Application: 60/337,460 →
Amplified Galanin, GALR2 and GALR3 genes, and GALR2 and GALR3 heterocomplex, and their involvement in cancer
Application: 60/340,863 →
Identification of ACK1 as an amplified oncogene and target for drug discovery
Application: 60/341,436 →
Heterocyclic arylsulfonamidobenzylic compounds
Application: 60/353,496 →
Arylsulfonamidobenzylic compounds
Application: 60/353,497 →
CD24 amplification in human tumors
Application: 60/365,192 →
Involvement of CTSZ gene in cancer
Application: 60/365,206 →
Amplified galanin, GALR2 and GALR3 genes, and GALR2 and GALR3 heterocomplex, and their involvement in cancer
Application: 60/375,027 →
Linked biaryl compounds
Application: 60/378,627 →
Amplification and overexpression of recQL5, CTXL, and USP13 in human tumors
Application: 60/382,606 →
Linked biaryl compounds
Application: 60/386,833 →
Amplification and overexpression of oncogenes
Application: 60/398,099 →
Amplification and overexpression of oncogenes
Application: 60/401,342 →
Piperidine derivatives
Application: 60/413,335 →
Receptor ligands and methods of modulating receptors
Application: 60/421,142 →
Antiinflammation agents
Application: 60/422,531 →
Receptor ligands and methods of modulating receptors
Application: 60/424,093 →
Fused heterocyclic compounds
Application: 60/424,456 →
Gene amplification in cancer
Application: 60/427,202 →
Fused bicyclic nitrogen-containing heterocycles
Application: 60/428,600 →
Amplification and overexpression of oncogenes
Application: 60/434,381 →
Amplified genes involved in cancer
Application: 60/434,434 →
Asthma and allergic inflammation modulators
Application: 60/435,366 →
Receptor ligands and methods of modulating receptors
Application: 60/444,153 →
CXCR3 antagonists
Application: 60/451,157 →
Gene amplification and overexpression in cancer
Application: 60/462,702 →
Gene amplification and overexpression in cancer
Application: 60/479,833 →
Asthma and allergic inflammation modulators
Application: 60/485,978 →
Pyrrolo[1,2-b]pyridazine derivatives
Application: 60/493,997 →
Arylsulfonamidobenzylic compounds
Application: 60/494,692 →
Salts and polymorphs of a potent antidiabetic compound
Application: 60/508,470 →
Triazole compounds having HSD1 inhibitory activity
Application: 60/515,537 →
Recreational swings and toddler attachments for swinging and spinning
Application: 60/523,463 →
Gene amplification and overexpression in cancer
Application: 60/524,050 →
Aryl Sulfonamide Compounds and uses related thereto
Application: 60/531,924 →
GPR40 modulators and methods for their use
Application: 60/548,741 →
Therapeutic modulation of PPARgamma activity
Application: 60/551,656 →
Pyrazole compounds having HSD1 inhibitory activity
Application: 60/556,013 →
Arylsulfones and uses related thereto
Application: 60/563,251 →
Arylsulfonamides and uses related thereto
Application: 60/564,376 →
Pyrrolo[2,3-d]pyrimidines that modulate ACK1 activity
Application: 60/583,682 →
Imidazolo-related compounds, compositions and methods for their use
Application: 60/583,822 →
Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their use
Application: 60/583,823 →
Furanopyrimidines
Application: 60/583,898 →
Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseases
Application: 60/583,901 →
Substituted benzofused heterocycles
Application: 60/601,223 →
Bisaryl-sulfonamides
Application: 60/601,578 →
Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders
Application: 60/601,579 →
Related Assignments (7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Sep 16, 2003
From: TULARIK INC.
To: CUMBRE INC.
Reel/Frame 014491/0871 →
Assignment of Assignor's Interest Sep 16, 2003
From: TULARIK INC.
To: CUMBRE INC.
Reel/Frame 014497/0560 →
Merger Jun 7, 2005
From: TULARIK INC.
To: ARROW ACQUISITION, LLC
Reel/Frame 016309/0003 →
Assignment of Assignor's Interest Oct 18, 2005
From: AMGEN SF, LLC
To: AMGEN INC.
Reel/Frame 016871/0736 →
Assignment of Assignor's Interest Apr 29, 2008
From: AMGEN SF, LLC
To: AMGEN INC.
Reel/Frame 020872/0365 →
Assignment of Assignor's Interest May 13, 2009
From: CUMBRE PHARMACEUTICALS INC.
To: CUMBRE IP VENTURES, L.P.
Reel/Frame 022678/0001 →
Assignment of Assignor's Interest Jan 15, 2015
From: CUMBRE IP VENTURES, L.P.
To: TENNOR THERAPEUTICS LIMITED
Reel/Frame 034721/0101 →